Introduction
Cartilage damage frequently occurs due to sports or progressive ageing. Once damaged, cartilage cannot be spontaneously repaired because of its avascularity and low cellular mitotic activity [1] . A range of clinical options emerged to repair focal lesions and damage to the articular surface. These approaches may reduce pain and increase mobility, but only to a limited extent and over a short-term period [2, 3] . Current strategies are not able to fully restore the native structure of cartilage which raises concerns about the long term performance of repaired cartilage [4] . These partial successes lead to significant research efforts to develop tissue engineering therapies for cartilage repair.
The main challenge for cartilage tissue engineering is the chondrocytes massive transition into fibroblastic cells during the in vitro culture process. Those de-differentiated cells form fibrocartilage instead of hyaline cartilage [5] . Additionally, chondrocytes availability is limited due to the size of biopsies that can be collected from the patient's own tissue, without causing the risk of morbidity of the site of explant. Moreover, the development of biodegradable polymers to perform the role of a temporary matrix is an important factor in the success of cell transplantation [6, 7] . Extracellular matrices (ECMs) provide a microenvironment for cells to maintain homeostasis and to retain the required differentiated state for specific tissues [8] . Among the many different ECM molecules, hyaluronic acid (HA) is the main glycosaminoglycan (GAG) in the mesenchyme during the early stage of chondrogenesis [9, 10] . In addition, HA is known to influence chondrocytes by triggering a sophisticated signaling pathway leading to enhancement of cellular functions [11, 12] .
However, the concentration of HA must be confined to a relatively low amount, since concentrations may reduce cell adhesion due its negative charge [13] . This disadvantage can be overcome by combining HA with positively charged polycations such as chitosan [14] . Chitosan (CHT), a partially deacetylated derivative from chitin, has the ability to interact with negatively charged molecules [15] . Due to its biocompatibility and biodegradability, chitosan has been widely applied in tissue engineering strategies [16] [17] [18] [19] . Additionally, chitosan is structurally similar to various GAGs found in articular cartilage [20] . Combining the advantages of both polysaccharides, CHT/HA scaffolds can be suitable candidates for cartilage tissue regeneration. The blend would be stabilized due to an ionic interaction between the positively charged chitosan and the negatively charged hyaluronic acid.
Chitosan has already been conjugated with hyaluronic acid to obtain a biomimetic matrix for chondrocytes [16, [21] [22] [23] [24] . Yamane et al. [22] developed chitosan-based hyaluronic acid polymer fibers by the wetspinning method. In the hybrid fibers, chondrocyte adhesion, proliferation, and also the synthesis of aggrecan and type II collagen, were significantly higher comparing to chitosan fibers.
Hsu et al. [24] studied chitosan-alginate-hyaluronan scaffolds, with or without covalent attachment, with RGD containing protein. The cell-seeded scaffolds showed neocartilage formation in vitro in the presence or absence of RGD. Tan et al. [21] demonstrated that chitosan-hyaluronic acid hydrogels allowed cell survivor, and cells retained the chondrogenic morphology.
The reported studies are focused on the superior biological effects that HA could provide, and its incorporation has not been studied in terms of physicochemical effects. Additionally, to our knowledge, the effect of varying the ratio between chitosan and hyaluronic acid, and, consequently, its influence in terms of both physicochemical and biological properties, has not been yet reported.
On the other hand, due to HA high water uptake and the lack of mechanical strength provided by natural polymers, the existing strategies combining CHT and HA for cartilage tissue engineering are very limited and usually consist in hydrogels [21, 25] . However, these hydrogels do not have the required mechanical strength to maintain the initial shape of the implanted scaffold. Consequently, they cannot be transplanted into large cartilaginous lesions in advanced degenerative diseases, such as osteoarthritis and rheumatoid arthritis. Moreover, the existing CHT/HA blends are usually used to produce scaffolds by techniques more complexes than the freeze-drying method, in which further research is needed to determine the adequate shape, pore size, and mechanical properties of a 3D fabrication for cartilage TE. The aim of this work was to prepare a new class of hybrid scaffolds composed of chitosan as a framework containing low concentrations of hyaluronic acid to mimic cartilage ECM composition.
The application of HA as a component of the cartilage scaffold biomaterial, could be a reasonable approach for enhancing chondrogenesis. We hypothesized that HA could provide superior effects on the formation, structural and biological properties of chitosan scaffolds, by providing a suitable microenvironment where chondrocytes may produce a cartilage-specific matrix for cartilage regeneration. To test this hypothesis, hyaluronic acid was added to chitosan solution in a final polymer concentration of 2% (w/v) to prepare 3D scaffolds by freeze-drying method [19] . Using this method, porous scaffolds are easily prepared with controllable pore size, uniform pore distribution and functional features. Four types of scaffolds were obtained containing either no HA (control, CHT), 1% (CHT/1HA), 5% (CHT/5HA), and 10% of HA (CHT/10HA). The physic-chemical properties and biological behavior of the developed scaffolds were evaluated to study the hyaluronic acid influence in the CHT scaffolds in different parameters, including pore size and geometry, mechanical properties, and cartilage ECM production.
Materials and methods

Materials
Chitosan medium molecular weight (M w 190.000-310.000, 75-85% deacetylation degree, viscosity 200-800 cps) and hyaluronic acid (#81, Lot Dev 00453, Mw 1.8 million) were purchased from Sigma-Aldrich. Before being used, chitosan was purified by recrystallization. Chitosan was dissolved in 1% (w/v) acetic acid solution and then filtered under vacuum through porous membranes (Whatman ashes filter paper, 20-25μm) into a Buckner flask. By adding a solution of sodium hydroxide, the pH of the solution was adjusted to 8, causing flocculation due to deprotonation and insolubility of the polymer at neutral pH. The polymer solution was then This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
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neutralized until the pH was equal to that of distilled water. Samples were frozen at −80 °C and lyophilized. Lysozyme from chicken egg white (lyophilized powder, ~100000 U/mg, stored at 4°C) and hyaluronidase from bovine tests (Type VIII, 300 U/mg, stored at -20°C) were purchased from Sigma-Aldrich.
Methods
Preparation of chitosan and hyaluronic acid scaffolds
Chitosan and hyaluronic acid were first separately dissolved (1% w/v) overnight at room temperature in diluted acetic acid (1% v/v) and subsequently mixed in different ratios (w/v) in a final polymer concentration of 2% (w/v). In order to obtain a cylindrical shape, the polymeric solutions were placed into plastic tubes and frozen for 1 day at -80°C. The plastic tubes were then cut in small pieces to obtain a scaffold dimension of 5 mm x Ø6 mm. After freeze-drying, the scaffolds were neutralized with a solution of NaOH (0.1M) and then freeze-dried again. Four types of scaffolds were obtained, containing 0% (control), 1%, 5% or 10% of hyaluronic acid (CHT; CHT/1HA; CHT/5HA; and CHT/10HA, respectively).
Physicochemical characterization
Morphology and pore size
Morphology of CHT/HA scaffolds was characterized by scanning electron microscopy. The scaffolds were gold-coated using a sputter coater (Cressington) for 60 seconds at a current of 40 mA.
Cross-sectional morphologies were viewed using a Philips XL 30 ESEM-FEG operated at 10 kV accelerating voltage. Pore size was measured using a submenu, consisting on a ruler tool, incorporated in the software of the SEM equipment. Once obtained overall cross-sectional images of the scaffolds, were selected several pores (more than 20). In each selected pore, the ruler tool This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. 8 8 measured the diameter of the pore by measuring the distance between two points. In each crosssectional image of the scaffolds, the average pore size was calculated.
Fourier Transform Infrared spectroscopy imaging measurements
FT-IR measurements were performed using a Perkin-Elmer Spectrum Spotlight 200 FTIR Microscope System in reflectance mode. The four scaffolds formulations and a sample of pure hyaluronic acid were analyzed without further modifications in the range of 720-1800 cm -1 . The selected region for chitosan identification was 1650 cm -1 which corresponds to C=O stretching of amide I [26] . The selected region for hyaluronic acid was 1045 cm -1 which corresponds to C-O-C bond stretching vibration of symmetric ester band [27, 28] . To obtain the chemical maps, a submenu incorporated in the software of the FT-IR equipment was used. Two ranges and three colors were selected. For chitosan, the range 1630-1670 cm -1 integrates the amide I characteristic peak and it is represented in green. For hyaluronic acid, the range 1025-1065 cm -1 integrates the ester characteristic peak and it is represented in red. The color yellow was selected to represent the presence of the two characteristic peaks in simultaneous. Spectra were collected in continuous scan mode for sample areas of 85x85 μm 2 with a spectral resolution of 16 cm -1 by averaging 15 scans for each spectrum.
Mechanical properties
Mechanical compression tests of the scaffolds were performed using an INSTRON 5543 (Instron Int.
Ltd., USA) up to 60% of strain, at room temperature. The testing machine was equipped with a 1 kN load cell and the loading rate was 2 mm/min. The compressive modulus was calculated in the initial linear section of the stress-strain curve, when the strain was lower than 10%. The mechanical
properties of the scaffolds were tested in both dry and wet state. In the wet state assay, scaffolds were immersed in PBS at pH 7.4 for 24 hours, in a shaking water bath at 37º C to simulate in vivo conditions and for complete hydration. Compressive mechanical tests were performed in n=6 per scaffold formulation in both assays. 
Swelling properties
The water sorption capacity of the scaffolds was determined by swelling of freeze-dried scaffolds (with known weights) in phosphate buffered saline (PBS, Gibco) at pH 7.4 for 3 days at 37°C. The swollen scaffolds were removed at predetermined time intervals (15min, 30min, 1h, 2h, 4h, 6h, 8h, 24h, 2 days, and 3 days) and immediately weighted with an analytical balance (Scaltec, Germany)
after the removal of excess of water by lying the surfaces on a filter paper (Whatman Pergamyn
Paper, 100x100 mm). The swelling ratio (SR) was calculated using the following equation (1):
Where W w and W d are the weights of the scaffolds at the swelling state and at the dry state, respectively.
Enzymatic Degradation
CHT/HA scaffolds were placed at pH 7.4 in PBS (control) or at pH 7.11 in an enzymatic solution containing 2 mg/mL of lysozyme [29] and 0.33 mg/mL of hyaluronidase [30] , in a shaking water bath at 37°C. The medium was replaced every third day. At predetermined time intervals (7 and 14 days) scaffolds were taken from the solutions and washed with distilled water three times to remove salts. The weight was measured after the scaffolds were immersed in 100% ethanol for 2 hours and dried for 1 day at room temperature. The percentage weight loss (%WL) of scaffolds was calculated according to the following equation (2):
Where, W i is the initial dry weight of scaffold and W f is the weight of the dry scaffold after incubation in the PBS or enzymatic solution. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. Prior to cell seeding, the scaffolds were sterilized with 70% (v/v) ethanol for 2 hours, rinsed three times in distilled water, and then they were immersed in PBS for 2 days. The seeding was performed by injection of a cell suspension, on which the cell concentration was adjusted to 0.5x10 6 cells in 20μL of medium (per scaffold). After incubation for 4 hours at 37°C in a 5% CO 2 atmosphere incubator, chondrocyte proliferation medium or chondrocyte differentiation medium (DMEM, 2mM glutamax (Gibco), 0.2mM Asap (Invitrogen), 100μg/mL penicillin/streptomycin, 0.4mM proline (Sigma-Aldrich), 100μg/mL Sodium Pyruvate (Sigma-Aldrich), and 50mg/mL ITS+premix (BD biosciences). Immediately before use: 10ng/mL TGF-β3 (R&D Systems) and 0.1μM dexamethasone (Sigma-Aldrich)) were added to the seeded scaffolds, according to the type of assay performed.
Biological assays
To analyze cell viability, proliferation and adhesion of CHT/HA scaffolds, articular bovine chondrocytes were seeded by injection at passage 3 in proliferation medium. Live/dead and MTT assays were performed at 1, 3, 7, 14, and 21 days, according to manufacturer's specifications, and This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
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scaffolds were further observed by scanning electron microscopy. To evaluate the chondrogenic phenotype maintenance, articular bovine chondrocytes were seeded by injection at passage 1 in differentiation medium. Safranin-O and Alcian Blue stainings, quantitative GAG and DNA assays, and SEM observation were performed. Chondrocyte medium was changed every third day to maintain an adequate supply of cell nutrients.
Live/dead assay
Scaffolds were deposited in a 48-well plate. To perform this assay, chondrocyte proliferation medium was aspirated from the wells and the seeded scaffolds were incubated with ethidium homodimer-1 (6 μM) and calcein-AM (4 mM) (Invitrogen) for 30 minutes in the dark at 37°C in a 5% CO 2 atmosphere incubator. Scaffolds were immediately examined in an inverted fluorescent microscope (Nikon Eclipse E600) using a FITC/Texas Red Filter. The images were captured using a color camera (Nikon FDX-35) and the QCapture software. Calcein-AM is enzymatically converted, producing fluorescent living cells, since live cells have intracellular esterase activity. Ethidium homodimer-1 is only able to enter dead cells and after binding to nuclei acids producing a red fluorescent signal.
MTT assay
Scaffolds were deposited in a 48-well plate and incubated with 1 mL of chondrocytes proliferation medium and 20 μL MTT solution (5 mg/mL, Gibco) per well for 2 hours at 37°C in a 5% CO 2 atmosphere incubator. MTT is a pale yellow substrate, which is reduced by living cells to formazan, which stains dark purple. This process requires active mitochondria and is, thus, an accurate measure of the metabolic activity of cells in a culture. At the above referred time intervals, MTT solution was added to each well. During this period, viable cells could reduce the MTT formazan. Images were captured using a color camera (Nikon SMZ-10A) and the MATRIX Vison SRGB 32Bit software. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
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Scanning Electron Microscopy observation
Chondrocytes adhesion on scaffolds was analyzed by SEM (n=2). CHT/HA scaffolds were immersed in 10% (v/v) formalin overnight at 4°C. Specimens were then dehydrated using sequential ethanol series (70%, 80%, 90%, 96%, and 100% (v/v), 1 hour in each, and critical point dried using a Balzers CPD 030 machine. The scaffolds were gold-sputtered as previously described for further observation by SEM operated at 10 kV accelerating voltage.
Histology
Safranin-O and alcian blue stainings were used to analyze cartilage tissue formation. Scaffolds were washed with PBS and fixed overnight in 10% formalin, and then dehydrated using sequential ethanol series (70%, 80%, 90%, 96%, and 100% (v/v), 1 hour in each). Once dehydrated, they were incubated in butanol overnight, and then in a solution containing butanol and paraffin (50:50) for 8
hours. Ultimately, the scaffolds were embedded in paraffin and 5 μm thick sections were cut using a microtome. After deparaffinazing with xylene and rehydratation using a graded ethanol series (from 100% to 70% (v/v)) the samples were stained. For the safranin-O staining, sections were counter stained with haematoxylin (Sigma-Aldrich) and fast green (Merk) to visualize cells and cell nuclei, respectively, and safranin-O (Sigma-Aldrich) for visualization of glycosaminoglycans in red. For alcian blue staining, sections were stained with alcian blue solution (1% in acetic acid) for 30 minutes to visualize extracellular GAGs in blue. After washing steps, the samples were counterstained with nuclear fast red for 5 minutes. Slides were assembled with resinous medium and mounted slides were examined under a light microscope (Nikon Eclipse E600). Representative images were captured using a digital camera (Nikon FDX-35) and QCapture software. Each assay was performed at either 1, 14, 21, and 35 days of culture in duplicate (n=2 per scaffold formulation).
Quantitative GAG and DNA assays
CHT/HA scaffolds were washed with PBS and frozen at -80°C for quantitative analysis of GAG expression and cell number. Subsequently, they were digested with 1 mg/mL proteinase K (Sigma- This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
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Aldrich) in Tris/EDTA buffer (pH 7.6) containing 18.5 μg/mL iodoacetamide and 1 μg/mL pepstatin A (Sigma-Aldrich) for 20 hour at 56°C. GAG content was spectrophotometrically determined with DMMB (Sigma-Aldrich) staining in PBE buffer (PBS containing 14.2 g/L Na 2 HPO 4 and 3.72 g/L Na 2 EDTA, pH 6.5) with a monochromatic microplate reader (TECAN Safire 2, Austria) at an absorbance of 520 nm. The standard curve for the GAG analysis was generated using chondroitin sulphate A (Sigma-Aldrich). Quantification of total DNA was determined with the CyQuant DNA kit, according to the manufacturer's description (Molecular Probes, Eugene, Oregon, USA), using a fluorescent plate reader (emission: 520 nm; excitation: 480 nm) (Perkin-Elmer, Victor 3, USA). The standard curve for DNA analysis was generated with λ DNA provided with the CyQuant DNA kit.
The assays were performed at 1, 14, 21, and 35 days of culture.
Statistical analysis
Each experiment was carried out in triplicate unless otherwise specified. All results are presented as mean ± standard deviation (SD). Experimental data were analyzed using single-factor Analysis of Variance (ANOVA) technique to assess statistical significance of results. Statistical significance was set to p-value ≤ 0.05 (*) or to p-value ≤ 0.01 (**).
Results and discussion
Physicochemical characterization of chitosan-hyaluronic acid scaffolds
Scaffolds preparation and microstructure observation
Concentrations of HA-based scaffolds are usually limited to 2% w/v, or less, because higher concentrations are too viscous for adequate mixing [31] . The morphologies of the scaffolds were investigated based on different ratios between CHT and HA. In order to characterize the microstructure morphology of chitosan and hyaluronic acid scaffolds, cross-sectional SEM images were obtained (Correia. Fig1) . CHT scaffolds showed a closed network pore configuration with .Fig1 C 10 ). This influence on porosity and pore structure when HA was incorporated in scaffolds of polycationic polymers was also found by Ren et al. [13] . The differences between the pore architecture are at least partially related to the homogeneity of the polymeric solution; i.e. how well are the two polymers mixed and dispersed in the solution. Since chitosan and hyaluronic acid have an opposite charge, an ionic bond between the carboxyl groups of HA and the amino groups of chitosan is expected [15] . As the concentration of HA increased in the CHT/HA formulation, the solution become more opaque. The incorporation of HA up to a concentration of 5% in a CHT solution yielded a well dispersed colloidal suspension. CHT/5HA suspension was stable indicating the formation of sub-micrometer complexes. In contrast, higher concentrations of HA jeopardized efficient mixture of both polymers, resulting in white precipitates.
These precipitates tended to aggregate and, consequently, after freeze-dried, resulted in a nonuniform pore geometry (Correia.Fig1 C 10 ). Mao et al. [32] also studied chitosan and hyaluronic acid blends, and correlated the formation of white precipitates with the high density of carboxyl groups in hyaluronic acid and amino groups in chitosan.
Pore size increased with concentrations of hyaluronic acid in chitosan scaffolds (Correia.Table1).
Fan et al. [31] reported the same influence of HA on scaffold pore size. CHT/10HA also exhibited the highest standard deviation in pore sizes due to the non-uniform pore geometry. The open pore network and a range in pore size between ≈77-97 μm, as observed in CHT/1HA and CHT/5HA scaffolds, rendered these scaffolds appropriate for cellular infiltration. Particularly, we hypothesize that articular bovine chondrocytes can be incorporated into the above mentioned scaffolds. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. scaffolds the quality of the blend was comprised. There could be seen more green and red areas, which corresponds to chitosan and hyaluronic acid alone, respectively, and less yellow, which corresponds to the homogeneously blended biomaterials.
Mechanical Properties
The mechanical properties of the scaffolds in tissue engineering applications are of great importance due to the necessity of structural stability to withstand stresses incurred during in vitro culture and in vivo implantation [31] .
Compressive mechanical tests were performed using acellular scaffolds in dry and wet state. The compressive modulus of the scaffolds is shown in Correia.Table1. All samples exhibited a spongelike behavior. For both assays, the addition of HA in chitosan networks reduced the mechanical strength of the scaffold, while it increased its flexibility. This behavior may essentially be due to the This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
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16 increase in pore size by increasing the HA concentration. It was interesting to notice that CHT/1HA
and CHT/5HA scaffolds had similar compressive modulus in dry and wet state, probably due to their similar pore network.
Beside to an increase in pore size, O'Brien et al. [33] reported a correlation between decreasing mechanical strength and non-uniform pore shape in HA-based scaffolds. This may explain the reason why CHT/10HA had a much lower compressive modulus.
In the dry state, the compressive modulus of CHT/HA scaffolds were lower but in the same order of magnitude when compared to the modulus of articular cartilage reported by Korhonen et al. [34] .
The compressive modulus in wet state was much lower compared to the dry state due to hyaluronic acid's ability for high water uptake. Since chitosan and hyaluronic acid are two natural polymers, this drawback in terms of mechanical strength was expected. However, the principal aim of incorporating HA into CHT scaffolds was to mimic the native cartilage ECM. The compressive modulus may further improve by the deposition of an extracellular matrix by chondrocytes in CHT/HA scaffolds.
Swelling Properties
Diffusion and exchange of nutrients (e.g. oxygen) and waste throughout the entire scaffold are related to the swelling properties of the scaffolds. Both chitosan and hyaluronic acid have an abundant number of hydrophilic groups, such as hydroxyl, amino and carboxyl groups, which can promote the water uptake in the structure [25] . The swelling ability was evaluated by soaking the scaffolds in PBS at 37°C for 3 days (Correia. Fig4) . The ratio between chitosan and hyaluronic acid significantly affected the scaffolds swelling properties. In the first 2 hours, all samples rapidly increased their weight. This rapidly weight increase continued until 8 hours. Then, the swelling ratio of all samples seemed to stabilize, and a slight increase could be observed with time. CHT scaffolds had the lowest values during the entire experiment, while CHT/10HA the highest. CHT/1HA and This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. 
In vitro enzymatic degradation
Scaffolds for tissue engineering are usually required to either degrade or be reabsorbed by the body after successful tissue regeneration. Chitosan/hyaluronic acid scaffolds were incubated in a solution with lysozyme and hyaluronidase, or in a solution with PBS (control), both at 37°C for 7 and 14 days, to evaluate the weight decrease in the biopolymers due to enzymatic degradation. The weight loss percentage of scaffolds as a function of incubation time is illustrated in Correia.Fig5.
To distinguish between enzymatic degradation and simple dissolution, we compared the weight loss of samples that had been placed in PBS (Correia.Fig5 (a)) to those that had been placed in PBS supplemented with lysozyme and hyaluronidase at 7 and 14 days (Correia. Fig5 (b) ). According to Correia.Fig5 (b) , the presence of HA rendered CHT scaffolds more susceptible to enzymatic degradation, which is most likely due to a higher porosity and better accessibility of cleavage sites by the enzymes. The hydrophilicity of HA also contributed to a higher degradation of CHT/HA scaffolds as it will enhance the interaction of the biomaterial with the enzymatic solution. After a high initial weight loss at day 7, the degradation rate of the samples generally appeared to slow down at day 14, which is most likely due to the gradual disappearance of hexasaccharide sequences susceptible for enzymatic degradation. The control experiment in PBS (Correia. Fig5 (a) ), showed that practically none of the scaffolds degrade in PBS after 14 days. The degradation of chitosan has already been tested in several in vitro studies [35] [36] [37] [38] . Most of these studies were, however, performed at low pH for optimal lysozyme activity. In our study the enzymatic degradation experiments were performed at higher pH, which resembles better degradation of the scaffolds in This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
18 18 physiological conditions. Hyaluronidase and lysozyme concentrations used in this study (0.33 mg/mL and 2 mg/mL, respectively) are not representative of their concentration in vivo. The largest single reservoir of hyaluronidase is the synovial fluid of diarthrodial joints (0.5 to 4 mg/mL) [39] .
Lysozyme commonly exists in various human body fluids and tissues, with concentrations ranging from 4 to 13 mg/L in serum [40] and from 450 to 1230 mg/L in tears [41] . The cell morphology and proliferation on CHT/HA scaffolds was further studied by scanning electron microscopy (Correia. Fig8) . In all scaffolds, chondrocytes were primarily localized in the superficial area at day 1 and 3, and displayed a spherical morphology (cell size diameter ≈ 10 μm).
In vitro
At day 7, a limited increase in cell number was observed but cells did not penetrate into the scaffolds.
At days 14 and 21, chondrocytes seeded in CHT/5HA scaffolds significantly proliferated into the inner areas of the scaffolds. In all scaffolds, even after 21 days of culture, the cells continued to display a normal spherical morphology, as observed in native cartilage.
Maintenance of chondrogenic phenotype
The round shape of chondrocytes is an indicator of phenotype retention and is essential for matrix formation [42] . The newly formed matrix was stained with safranin-O (Correia. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. it was interesting to notice that most chondrocytes agglomerated to form very large aggregates adherent to the scaffolds. The aggregates were located on the superficial area. Hardly any penetration of cells in the scaffolds was observed. These events were also reported by Zhao et al. [43] .
CHT/1HA and CHT/5HA showed an enhanced cell-material interactions and ECM production, with enhanced glycosaminoglycans production (Correia. Fig11) . At day 1, chondrocytes were in aggregates in all specimens, but at day 14 they were better spread and attached. At days 14 and 21, improved chondrocyte dispersion could be noticed in CHT/1HA and CHT/5HA scaffolds. In all specimens lacunae formation was seen in the matrix surrounding the chondrocytes. The morphology of these lacunas shows similarities to natural cartilage.
Chondrogenic activity evaluation
It is known that when chondrocytes maintain their natural spherical shape they produce more GAGs and higher collagen type II versus collagen type I ratio [44] [45] [46] . Cell proliferation and ECM formation were quantified by DNA and GAG assays, respectively. In GAG quantification assay This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. A higher value of GAG/DNA ratio indicates a higher degree of differentiation of the cells [47] . For GAG/DNA ratio (Correia. Fig12 (c) ), it could be seen that at day 35, scaffolds with higher amount of hyaluronic acid (CHT/5HA and CHT/10HA) induced a higher ratio. Although CHT/1HA had the highest amount of cells in DNA quantification, CHT/5HA had the highest GAG versus DNA ratio.
This may imply that CHT/5HA scaffolds are the formulation which most favors cartilage ECM production, rendering them attractive for cartilage TE.
Physicochemical effects of CHT/HA scaffolds on cartilage regeneration
The key challenge for biomedical researchers is how to design and control material properties in order to achieve a specific biological response [48] . It is well established that physicochemical properties of materials can regulate biological responses, such as differentiation of stem cells [49] , proliferation of fibroblasts [50] , gene delivery [51] , and cell death [52] .
CHT/1HA and CHT/5HA scaffolds exhibited a uniform pore network with high porosity This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. 
Conclusions
The incorporation of hyaluronic acid up to a concentration of 5% in chitosan scaffolds improved the physicochemical properties and biological properties of CHT scaffolds. It enhanced pore network configuration, increased pore size, swelling ratio and degradation rate compared to pure CHT scaffolds. Higher concentrations of HA resulted in heterogeneous blends with irregular and collapsed pore networks, particularly CHT/5HA scaffolds favored chondrocyte adhesion, cell proliferation, and cartilage matrix production compared to pure CHT scaffolds and other CHT/HA blends.
The biological outcome of CHT/HA scaffolds seems to be influenced by physicochemical factors, such as polymer dispersion, pore network configuration, pore size, water uptake ability, and mechanical strength. However, other studies are required to elucidate case by case the dependence of biological response to physical properties, and to categorize the relative weight of different physical and chemical factors. This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
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Our results suggest that the freeze-dried scaffolds of CHT and HA could have potential use in the regeneration of cartilaginous lesions caused by various joint diseases, including osteoarthritis and rheumatoid arthritis.
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